Abstract

IgG secreted by B cells carry asparagine N(297)-linked glycans in the fragment crystallizable (Fc) region. Changes in Fc glycosylation are related to health or disease and are functionally relevant, as IgG without Fc glycans cannot bind to Fcɣ receptors or complement factors. However, it is currently unknown whether ɣ-heavy chain (ɣHC) glycans also influence the function of membrane-bound IgG-B-cell receptors (BCR) and thus the outcome of the B-cell immune response. Here, we show in a germinal center (GC)-derived human B-cell line that ɣHC glycans do not affect membrane expression of IgG-BCRs. Furthermore, antigen binding or other BCR-facilitated mechanisms appear unaffected, including BCR downmodulation or BCR-mediated signaling. As expected, secreted IgG lacking Fc glycosylation is unable to carry out effector functions. Together, these observations indicate that IgG-Fc glycosylation serves as a mechanism to control the effector functions of antibodies, but does not regulate the activation of IgG-switched B cells, as its absence had no apparent impact on BCR function.

IgG molecules are glycosylated at a conserved asparagine residue of their constant region, and this modification is essential for the effector functions of their soluble form, such as complement activation and binding to Fcɣ receptors. Here authors show that in a model B-cell line, neither the expression nor the function of the membrane-bound form of IgG depend on glycosylation.

Details

Title
N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line
Author
Kissel, Theresa 1   VIAFID ORCID Logo  ; Derksen, Veerle F. A. M. 1   VIAFID ORCID Logo  ; Bentlage, Arthur E. H. 2   VIAFID ORCID Logo  ; Koeleman, Carolien 3 ; Hafkenscheid, Lise 1   VIAFID ORCID Logo  ; van der Woude, Diane 1   VIAFID ORCID Logo  ; Wuhrer, Manfred 3   VIAFID ORCID Logo  ; Vidarsson, Gestur 2   VIAFID ORCID Logo  ; Toes, René E. M. 1   VIAFID ORCID Logo 

 Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978) 
 University of Amsterdam, Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262) 
 Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978) 
Pages
393
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2912141872
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.